China Novel Oral AntiCoagulants (NOAC) Market Research Report Forecast 2017-2021

June 2017 | 115 pages | ID: C718E3AC38DEN
S&P Consulting

Abstracts

The China Novel Oral AntiCoagulants (NOAC) Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Novel Oral AntiCoagulants (NOAC) industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Novel Oral AntiCoagulants (NOAC) market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer, Inc. (US)
Bayer Healthcare AG (Germany)
GlaxoSmithKline Plc. (UK)
Boehringer Ingelheim (Germany)
Sanofi S.A. (France)
Abbott India Limited (India)
Aspen Holdings (South Africa)
Bristol-Myers Squibb Company (US)
Eisai Inc. (US)

China Novel Oral AntiCoagulants (NOAC) Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

China Novel Oral AntiCoagulants (NOAC) Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 NOVEL ORAL ANTICOAGULANTS (NOAC) MARKET OVERVIEW

1.1 Product Overview and Scope of Novel Oral AntiCoagulants (NOAC)
1.2 Novel Oral AntiCoagulants (NOAC) Market Segmentation by Type
  1.2.1 China Production Market Share of Novel Oral AntiCoagulants (NOAC) by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Novel Oral AntiCoagulants (NOAC) Market Segmentation by Application
  1.3.1 Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Novel Oral AntiCoagulants (NOAC) (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON NOVEL ORAL ANTICOAGULANTS (NOAC) INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Novel Oral AntiCoagulants (NOAC) Industry

CHAPTER 3 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) MARKET COMPETITION BY MANUFACTURERS

3.1 China Novel Oral AntiCoagulants (NOAC) Production and Share by Manufacturers (2015 and 2016)
3.2 China Novel Oral AntiCoagulants (NOAC) Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Novel Oral AntiCoagulants (NOAC) Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Novel Oral AntiCoagulants (NOAC) Manufacturing Base Distribution, Production Area and Product Type
3.5 Novel Oral AntiCoagulants (NOAC) Market Competitive Situation and Trends
  3.5.1 Novel Oral AntiCoagulants (NOAC) Market Concentration Rate
  3.5.2 Novel Oral AntiCoagulants (NOAC) Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Novel Oral AntiCoagulants (NOAC) Capacity, Production and Growth (2012-2017)
4.2 China Novel Oral AntiCoagulants (NOAC) Revenue and Growth (2012-2017)
4.3 China Novel Oral AntiCoagulants (NOAC) Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Novel Oral AntiCoagulants (NOAC) Production and Market Share by Type (2012-2017)
5.2 China Novel Oral AntiCoagulants (NOAC) Revenue and Market Share by Type (2012-2017)
5.3 China Novel Oral AntiCoagulants (NOAC) Price by Type (2012-2017)
5.4 China Novel Oral AntiCoagulants (NOAC) Production Growth by Type (2012-2017)

CHAPTER 6 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) MARKET ANALYSIS BY APPLICATION

6.1 China Novel Oral AntiCoagulants (NOAC) Consumption and Market Share by Application (2012-2017)
6.2 China Novel Oral AntiCoagulants (NOAC) Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) MANUFACTURERS ANALYSIS

7.1 Pfizer, Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Bayer Healthcare AG (Germany)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 GlaxoSmithKline Plc. (UK)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Boehringer Ingelheim (Germany)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Sanofi S.A. (France)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Abbott India Limited (India)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Aspen Holdings (South Africa)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Bristol-Myers Squibb Company (US)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Eisai Inc. (US)
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 NOVEL ORAL ANTICOAGULANTS (NOAC) MANUFACTURING COST ANALYSIS

8.1 Novel Oral AntiCoagulants (NOAC) Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Novel Oral AntiCoagulants (NOAC) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Novel Oral AntiCoagulants (NOAC) Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) MARKET FORECAST (2017-2021)

12.1 China Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2017-2021)
12.2 China Novel Oral AntiCoagulants (NOAC) Production, Consumption Forecast by Regions (2017-2021)
12.3 China Novel Oral AntiCoagulants (NOAC) Production Forecast by Type (2017-2021)
12.4 China Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Application (2017-2021)
12.5 Novel Oral AntiCoagulants (NOAC) Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Novel Oral AntiCoagulants (NOAC)
Figure China Production Market Share of Novel Oral AntiCoagulants (NOAC) by Type 1n 2016
Table Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application in 2016
Figure China Novel Oral AntiCoagulants (NOAC) Revenue (Million USD) and Growth Rate (2012-2021)
Table China Novel Oral AntiCoagulants (NOAC) Capacity of Key Manufacturers (2015 and 2016)
Table China Novel Oral AntiCoagulants (NOAC) Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Novel Oral AntiCoagulants (NOAC) Capacity of Key Manufacturers in 2015
Figure China Novel Oral AntiCoagulants (NOAC) Capacity of Key Manufacturers in 2016
Table China Novel Oral AntiCoagulants (NOAC) Production of Key Manufacturers (2015 and 2016)
Table China Novel Oral AntiCoagulants (NOAC) Production Share by Manufacturers (2015 and 2016)
Figure 2015 Novel Oral AntiCoagulants (NOAC) Production Share by Manufacturers
Figure 2016 Novel Oral AntiCoagulants (NOAC) Production Share by Manufacturers
Table China Novel Oral AntiCoagulants (NOAC) Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers
Table 2016 China Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers
Table China Market Novel Oral AntiCoagulants (NOAC) Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Novel Oral AntiCoagulants (NOAC) Average Price of Key Manufacturers in 2015
Table Manufacturers Novel Oral AntiCoagulants (NOAC) Manufacturing Base Distribution and Sales Area
Table Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
Figure Novel Oral AntiCoagulants (NOAC) Market Share of Top 3 Manufacturers
Figure Novel Oral AntiCoagulants (NOAC) Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Novel Oral AntiCoagulants (NOAC) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Pfizer, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer, Inc. (US) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer, Inc. (US) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Bayer Healthcare AG (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Healthcare AG (Germany) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Healthcare AG (Germany) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc. (UK) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim (Germany) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim (Germany) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Sanofi S.A. (France) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi S.A. (France) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi S.A. (France) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Abbott India Limited (India) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott India Limited (India) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott India Limited (India) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Aspen Holdings (South Africa) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Aspen Holdings (South Africa) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Aspen Holdings (South Africa) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Bristol-Myers Squibb Company (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Company (US) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Company (US) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Table Eisai Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eisai Inc. (US) Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2012-2017)
Table Eisai Inc. (US) Novel Oral AntiCoagulants (NOAC) Market Share (2012-2017)
Figure Production Revenue Share of Novel Oral AntiCoagulants (NOAC) by Type (2012-2017)
Figure 2015 Revenue Market Share of Novel Oral AntiCoagulants (NOAC) by Type
Table China Novel Oral AntiCoagulants (NOAC) Price by Type (2012-2017)
Figure China Novel Oral AntiCoagulants (NOAC) Production Growth by Type (2012-2017)
Table China Novel Oral AntiCoagulants (NOAC) Consumption by Application (2012-2017)
Table China Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application (2012-2017)
Figure China Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application in 2015
Table China Novel Oral AntiCoagulants (NOAC) Consumption Growth Rate by Application (2012-2017)
Figure China Novel Oral AntiCoagulants (NOAC) Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Novel Oral AntiCoagulants (NOAC)
Figure Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
Figure Novel Oral AntiCoagulants (NOAC) Industrial Chain Analysis
Table Raw Materials Sources of Novel Oral AntiCoagulants (NOAC) Major Manufacturers in 2015
Table Major Buyers of Novel Oral AntiCoagulants (NOAC)
Table Distributors/Traders List
Figure China Novel Oral AntiCoagulants (NOAC) Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate Forecast (2017-2021)
Table China Novel Oral AntiCoagulants (NOAC) Production, Import, Export and Consumption Forecast (2017-2021)
Table China Novel Oral AntiCoagulants (NOAC) Production Forecast by Type (2017-2021)
Table China Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Application (2017-2021)